Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05312177 · ClinicalTrials.gov registry record
Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)
A clinical trial of Congenital Heart Disease and Down Syndrome, sponsored by Carelon Research.
- Completed
- Registry status
- 273
- Enrollment target
- 14
- Study locations
NCT05312177 is a study of Congenital Heart Disease and Down Syndrome that has completed, run by Carelon Research. The registered enrollment target is 273 participants, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (42% lower). The trial reports 14 study locations across 14 states.
The verdict
NCT05312177, a study of Congenital Heart Disease and Down Syndrome, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 273 participants
- Enrollment target
- 14
- Study locations
Study Summary
The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous or planned CHD surgery.
Conditions Studied
Interventions
- OTHER Stanford Binet Intelligence Scales, Fifth Edition
- OTHER Vineland Adaptive Behavior Scales Third Edition
- OTHER Peabody Picture Vocabulary Test, Fifth Edition
- OTHER Expressive Vocabulary Test, Third Edition
- OTHER Leiter International Performance Scale, Third Edition
Study Locations (14)
Delaware
- Alfred I. duPont Hospital for Children - Wilmington
District of Columbia
- Children's National Hospital - Washington D.C.
Georgia
- Children's Healthcare of Atlanta at Egleston - Atlanta
Indiana
- Riley Children's Hospital - Indianapolis
Massachusetts
- Boston Children's Hospital - Boston
Michigan
- University of Michigan Health System/Mott Hospital - Ann Arbor
Missouri
- Children's Mercy Hospital - Kansas City
New York
- Columbia College of Physicians and Surgeons - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05312177
The ClinicalTrials.gov registry entry for NCT05312177 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (42% lower). The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 5 interventions - of which Stanford Binet Intelligence Scales, Fifth Edition is the first listed.
NCT05312177 reports 14 study locations spanning 14 distinct geographic areas - top geographies include Delaware, District of Columbia, Georgia.
Frequently Asked Questions
What is clinical trial NCT05312177 about?
NCT05312177 is a clinical study titled "Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)". The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous ...
What is the current status of trial NCT05312177?
This trial is currently completed. The enrollment target is 273 participants. The study started on 2022-05-01. Estimated completion is 2023-12-31.
What conditions does trial NCT05312177 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Down Syndrome.
What interventions are being tested in trial NCT05312177?
The interventions under investigation include: Stanford Binet Intelligence Scales, Fifth Edition (OTHER), Vineland Adaptive Behavior Scales Third Edition (OTHER), Peabody Picture Vocabulary Test, Fifth Edition (OTHER), Expressive Vocabulary Test, Third Edition (OTHER), Leiter International Performance Scale, Third Edition (OTHER).
Who is sponsoring clinical trial NCT05312177?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05312177 being conducted?
This trial has 14 study locations across Delaware, District of Columbia, Georgia, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.